Literature DB >> 2562338

Combined hepatocellular-cholangiocarcinoma associated with dermatomyositis.

Y Horie1, M Yamada, K Nakai, H Kawasaki, C Hirayama, K Matsui, N Kambe, S Shimao.   

Abstract

A 56 year old female developed combined hepatocellular cholangiocarcinoma associated with dermatomyositis. Serum tumour markers except for carbohydrate antigen (CA 19-9; 6400 ng/ml) were within normal range. Despite extensive chemotherapy, no clinical response was obtained and the patient's course deteriorated after 4 months. Macroscopically, the liver was mainly occupied by hepatocellular carcinoma but cholangiocarcinoma was found in the hilum. This is the first case of a rare association of combined hepatocellular-cholangiocarcinoma and dermatomyositis.

Entities:  

Mesh:

Year:  1989        PMID: 2562338     DOI: 10.1111/j.1440-1746.1989.tb00812.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Dermatomyositis associated with hepatocellular carcinoma in an elderly female patient with hepatitis C virus-related liver cirrhosis.

Authors:  Nobuyuki Toshikuni; Rikako Torigoe; Mikio Mitsunaga; Akiyoshi Omoto; Koji Nakashima
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

2.  Hepatocellular carcinoma,polymyositis,rhabdomyolysis,and acute renal failure.

Authors:  Mi-Jeong Kim; Jin-A Kim; Mi-Sook Sung; Jun-Ki Min
Journal:  J Korean Med Sci       Date:  2004-12       Impact factor: 2.153

3.  Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma.

Authors:  Seung-Jung Kee; Tae-Jong Kim; Sung-Ji Lee; Young-Nan Cho; Seong-Chang Park; Jong-Sun Kim; Jeong-Chul Kim; Hyung-Sik Kang; Shin-Seok Lee; Yong-Wook Park
Journal:  Rheumatol Int       Date:  2008-09-20       Impact factor: 3.580

4.  HBV vaccine and dermatomyositis: is there an association?

Authors:  Arie Altman; Martine Szyper-Kravitz; Yehuda Shoenfeld
Journal:  Rheumatol Int       Date:  2007-11-23       Impact factor: 3.580

5.  Dermatomyositis in a Patient with Cholangiocarcinoma Detected by an [(18)F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scan.

Authors:  Koung Jin Suh; Jin Kyun Park; Seongcheol Cho; Hyunkyung Park; Hae Woon Baek; Kyoungbun Lee; Dong Soo Lee; Kyung-Hun Lee
Journal:  Cancer Res Treat       Date:  2015-03-18       Impact factor: 4.679

Review 6.  Dermatomyositis Induced by Hepatitis B Virus-related Hepatocellular Carcinoma: A Case Report and Review of the Literature.

Authors:  Jen-Wei Chou; Yin-Lan Lin; Ken-Sheng Cheng; Po-Yuan Wu; Teressa Reanne Ju
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

Review 7.  Dermatomyositis as an extrahepatic manifestation of hepatitis B virus-related hepatocellular carcinoma: A case report and literature review.

Authors:  Juqiang Han; Shuai Wang; Thomas Ngai Yeung Kwong; Jian Liu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.